Clinical cases of parasitoses and fungal infections important from medical point of view

• Autorzy: Blaszkowska J. , Goralska K.
• Języki publikacji: PL

Abstrakty

EN

Most important infectious diseases which pose a risk to human health and life are associated with parasites transmitted by a variety of arthropod vectors, or from animal to man. Some of these (malaria, toxoplasmosis, leishmaniosis, dirofilariosis, alveococcosis, cystic echinococcosis) still represent a serious public health problem in many regions in the world. This review describes the epidemiological and clinical aspects of important parasitoses and fungal infections from a medical point of view. It should be emphasized that the development of invasive disease depends on both host (susceptibility/resistance) and parasite factors (pathogenicity/virulence); an immunocompromised state can favour opportunistic parasitic infections: toxoplasmosis, cryptosporidiosis, giardiosis, cyclosporidiosis, blastocystosis and strongyloidosis. This article highlights the role of free-living amoebae in the pathogenesis and transmission of human diseases, the high pathogenicity of Echinococcus multilocularis, and the growing importance of ticks as a reservoir and vector for numerous dangerous pathogens (e.g., Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia microti). It also discusses the diagnostic problems of toxoplasmosis including cross-reactions in serological tests and reviews the search for new drugs and vaccines against toxoplasmosis. Attention is increasingly paid to the role played by the human microbiome in maintaining homeostasis and in the development of fungal infections. This review also presents the most common human superficial fungal infections and the role of Candida albicans infection in the pathogenesis of irritable bowel syndrome.

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2016
• Tom: 62
• Numer: 4
• Opis fizyczny: p.255-265,ref.

Twórcy

autor

Blaszkowska J.

• Department of Diagnostics and Treatment of Parasitic Diseases and Mycoses, Medical University of Lodz, pl.Hallera 1, 90-647 Lodz, Poland

autor

Goralska K.

• Department of Biology and Medical Parasitology, Medical University of Lodz, pl.Hallera 1, 90-647 Lodz, Poland

Bibliografia

• [1] Cox F.E.G. 2002. .History of human parasitology. Clinical Microbiology Reviews 5: 595-612. doi: 10.1128/CMR.15.4.595-612.2002
• [2] World Malaria Report 2015. World Health Organization. http://apps.who.int/iris/bitstream/10665/20008/1/ 9789241565158_eng.pdf
• [3] Jaffry K.T., Ali S., Rasool A., Raza A., Gill Z.J., 2009. Zoonoses. International Journal of Agriculture and Biology 11: 217-220.
• [4] Taylor L.H., Latham S.M., Woolhouse M.E. 2001. Risk factors for human disease emergence. Philosophical Transactions of the Royal Society of London B: Biological Sciences 356: 983-989.
• [5] Visvesvara G.S. 2013. Infections with free-living amebae. In: Handbook of Clinical Neurology 114. (Eds. H.H. Garcia, H.B. Tanowitz, O.H. del Brutto). Elsevier B.V.:153-168. doi:10.1016/B978-0-444-53490-3.00010-8
• [6] Behera H.S., Satpathy G., Tripathi M. 2016. Isolation and genotyping of Acanthamoeba spp. from Acanthamoeba meningitis/meningoencephalitis (AME) patients in India. Parasites and Vectors 9: 442. doi:10.1186/s13071-016-1729-5
• [7] Lorenzo-Morales J., Khan N.A., Walochnik J. 2015. An update on Acanthamoeba keratitis: diagnosis, patho genesis and treatment. Parasite 22: 10. doi:10.1051/parasite/2015010
• [8] Torgerson P.R., Keller K., Magnotta M., Ragland N. 2010. The global burden of alveolar echinococcosis. PLOS Neglected Tropical Diseases 4: e722.doi:10.1371/journal.pntd.0000722
• [9] Nahorski W.L., Knap J.P., Pawłowski Z.S. Krawczyk M., Polański J., Stefaniak J., Patkowski W., Szostakowska B., Pietkiewicz H., Grzeszczuk A., Felczak-Korzybska I., Gołąb E., Wnukowska N., Paul M., Kacprzak E., Sokolewicz-Bobrowska E., Niścigorska-Olsen J., Czyrznikowska A., Chomicz L., Cielecka D., Myjak P. 2013. Human alveolar echinococcosis in Poland: 1990–2011. PLoS Neglected Tropical Diseases 7: e1986.
• [10] Rojas C.A.A., Romig T., Lightowlers M.W. 2014. Echinococcus granulosus sensu lato genotypes infecting humans-review of current knowledge. International Journal of Parasitology 44: 9-18. doi:10.1016/j.ijpara.2013.08.008
• [11] Romig T., Ebi D., Wassermann M. 2015. Taxonomy and molecular epidemiology of Echinococcus granulosus sensu lato. Veterinary of Parasitology 213: 76-84. doi:10.1016/j.vetpar.2015.07.035
• [12] Sadjjadi S.M., Mikaeili F., Karamian M., Maraghi S., Sadjjadi S.F., Shariat-Torbaghan S., Kia E.B. 2013. Evidence that the Echinococcus granulosus G6 genotype has an affinity for the brain in humans. International Journal of Parasitology 43: 875-877.
• [13] Bulletin infectious diseases and poisonings in Poland in 2015. National Institute of Public Health – National Institute of Hygiene – Department of Epidemiology; Chief Sanitary Inspectorate – Department for Communicable Disease and Infection Prevention and Control. Warsaw 2016. http://www.old.pzh.gov.pl/oldpage/epimeld/2015/ Ch_ 2015.pdf
• [14] Sohn W-M., Kim H-M., Chung D-I., Yee S.T. 2000. The first human case of Trichinella spiralis infection in Korea. The Korean Journal of Parasitology 38: 111-115.
• [15] Pozio E., Sacchini D., Tamburrini A., Alberici F. 2001. Failure of mebendazole in the treatment of humans with Trichinella spiralis infection at the stage of encapsulating larvae. Clinical Infectious Diseases 32: 638-642.
• [16] Kirjušina M., Deksne G., Marucci G., Bakasejevs E., Jahundoviča I., Daukšte A., Zdankowska A., Bērziņa Z., Esīte Z., Bella A., Galati F., Krūmina A., Pozio E. 2015. A 38-year study on Trichinella spp. in wild boar (Sus scrofa) of Latvia shows a s incidence with an increased parasite biomass in the last decade. Parasites and Vectors 8: 137. doi:10.1186/s13071-015-0753-1
• [17] Roberts T., Stark D., Harkness J., Ellis J. 2014. Update on the pathogenic potential and treatment options for Blastocystis sp. Gut Pathogens 6: 17-26. doi: 10.1186/1757-4749-6-17
• [18] Popruk S., Pintong A., Prayong Radomyos P. 2013. Diversity of Blastocystis subtypes in humans. Journal of Tropical Medicine and Parasitology 36: 88-97.
• [19] Barua P., Khanum H., Haque R., Najib F., Kabir M. 2015. Establishment of Blastocystis hominis in-vitro culture sing fecal samples from infants in slum area of Mirpur, Dhaka, Bangladesh. Acta Medica International 2: 40-47.
• [20] El Safadi D., Gaayeb L., Meloni D., Cian A., Poirier P., Wawrzyniak I., Delbac F., Dabboussi F., Delhaes L., Seck M., Hamze M., Riveau G., Viscogliosi E. 2014. Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infectious Diseases 14:164. doi: 10.1186/1471-2334-14-164
• [21] Duda A., Kosik-Bogacka D., Lanocha-Arendarczyk N., Kołodziejczyk L., Lanocha A. 2015. The prevalence of Blastocystis hominis and other protozoan parasites in soldiers returning from peacekeeping missions. American Journal of Tropical Medicine and Hygiene 92: 805-806. doi:10.4269/ajtmh.14-0344
• [22] CDC. Parasites – Leishmaniasis. Epidemiology & Risk Factors. http://www.cdc.gov/parasites/leishmaniasis/biology.html
• [23] Wani G.M., Ahmad S.M., Khursheed B. 2015. Clinical study of cutaneous leishmaniasis in the Kahmir Valley. Indian Dermatology Online Journal 6: 387-392.
• [24] Motta A.C.F., Lopes M.A., Ito F.A., Carlos-Bregni R., de Almeida O.P., Roselino A.M. 2007. Oral leishmaniasis: a clinicopathological study of 11 cases. Oral Diseases 13: 335-340. doi:0.1111/j.1601-0825.2006.01296x
• [25] Garcia de Marcos J.A., Dean Ferrer A., Alamillos Granados F., Ruiz Masera J.J., Cortes Rodriguez B., Vidal Jimenez A., Garcia Lainez A., Lozano Rodriguez-Mancheno A. 2007. Localized leishmaniasis of the oral mucosa. A report of three cases. Medicina Oral, Patologia Oral y Cirugia Bucal 12: 281-286.
• [26] Passi D., Sharma S., Dutta S., Gupta C. 2014. Localized leishmaniasis of oral mucosa: report of an unusual clinicopathological entity. Case Reports in Dentistry: 1-5. doi:10.1155/2014/753149
• [27] da Costa D.C.S., Palmeiro M.R., Moreira J.S., da Costa Martins A.C., da Silva A.F., de Fatima Madeira M., Quintella L.P., Confort E.M., de Oliveira Schubach A., da Conceicao Silva F., Valete-Rosalino C.M. 2014. Oral manifestations in the american tegumentary leishmaniasis. PLOS ONE 9: e109790.doi:10.1371/journal.pone.019790
• [28] Vannier E., Gewurz B.E, Krause P.J. 2008. Human babesiosis. Infectious Disease Clinics of North America 22: 469–ix. doi:10.1016/j.idc.2008.03.010
• [29] Szymczak J., Donskow-Łysoniewska K., Doligalska M. 2016. B cells and CD4+ T cells play a key role in resistance to Babesia microti infection in mice. Annals of Parasitology 62 (Suppl.): 208.
• [30] Milewska-Bobula B., Lipka B., Gołąb E., Dębski R., Marczyńska M., Paul M., Panasiuk A., Seroczyńska M., Mazela J., Dunin-Wąsowicz D. 2015. Proponowane postępowanie w zarażeniu Toxoplasma gondii u ciężarnych i ich dzieci. Przegląd Epidemiologiczny 69: 403-410.
• [31] Liesen A.P., de Aquino T.M., Carvalho C.S., Lima V.T., de Araújo J.M.; de Lima J.G., de Faria A.R., de Melo E.J.T., Alves A.J., Alves E.W., Alvesc E.W., Alvesb A.Q., Góes A.J.S. 2010. Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. European Journal of Medicinal Chemistry 45: 3685-3691. http://dx.doi.org/10.1016/j.ejmech.2010.05.017
• [32] Dzitko K., Paneth A., Plech T., Pawełczyk J., Stączek P., Stefańska J., Paneth P. 2014. 1,4-disubstituted thiosemicarbazide derivatives are potent inhibitors of Toxoplasma gondii proliferation. Molecules 19: 9926-9943. doi:10.3390/molecules19079926
• [33] Clemens J., Moorthy V. 2016. Implementation of RTS,S/AS01 Malaria vaccine – the need for further evidence. New England Journal of Medicine 374: 2596-2597. doi:10.1056/NEJMe1606007
• [34] Lim S.S-Y., Othman R.Y. 2014. Recent advances in Toxoplasma gondii immunotherapeutics. Korean Journal of Parasitology 52: 581-593. http://dx.doi.org/ 10.3347/kjp.2014.52.6.581
• [35] Grzybowski M.M., Gatkowska J.M., Dziadek B., Dzitko K., Długońska H. 2015. Human toxoplasmosis: a comparative evaluation of the diagnostic potential of recombinant Toxoplasma gondii ROP5 and ROP18 antigens. Journal of Medical Microbiology 64: 1201-1207. doi:10.1099/jmm.0.000148
• [36] Beger B., von Loewenich F., Goetze E., Moergel M., Walter C. 2016. Leech related Aeromonas veronii complex infection after reconstruction with a microvascular forearm flap. Journal of Maxillofacial and Oral Surgery. doi:10.1007/s12663-016-0961-z
• [37] Litwinowicz A, Błaszkowska J. 2014. Preventing infective complications following leech therapy: Elimination of symbiotic Aeromonas spp. from the intestine of Hirudo verbana, using antibiotic feeding. Surgical Infections 15: 757-762. doi:10.1089/sur.2014.036
• [38] Góralska K. 2014. Interactions between potentially pathogenic fungi and natural human microbiota. Annals of Parasitology 60: 159-168.
• [39] Gouba N., Drancourt M. 2015. Digestive tract mycobiota: a source of infection. Médecine et Maladies Infectieuses 45: 9-16. doi:10.1016/j.medmal.2015.01.007
• [40] Underhill D.M., Iliev I.D. 2014. The mycobiota: interactions between commensal fungi and the host immune system. Nature Review. Immunology 14: 405-416. doi:10.1038/nri3684
• [41] Mukherjee P.K., Sendid B., Hoarau G., Colombel JF., Poulain D., Ghannoum M.A. 2014. Mycobiota in gastrointenstinal diseases. Nature Reviews. Gastroenterology and Hepatology. doi: 10.1038/nrgastro.2014.188.
• [42] Ligaarden S.C., Lydersen S., Farup P.G. 2012. IgG and IgG4 antibodies in subjects with irri bowel syndrome: a case control study in the general population. BMC Gastroenterology 12: 166. doi:10.1186/1471-230X-12-166
• [43] Kumamoto C.A. 2011. Inflammation and gastrointenstinal Candida colonization. Current Opinion in Microbiology 14: 386-391. doi:10.1016/j.mib.2011.07.015
• [44] Zwolińska-Wcisło M., Brzozowski T., Budak A., Kwiecień S., Śliwowski Z., Drozdowicz D., Trojanowska D., Rudnicka-Sosin L., Mach T., Konturek S.J., Pawlik W.W. 2009. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. Journal of Physiology and Pharmacology 60: 107-118.
• [45] Hanna L., Cruz S.A. 2011. Candida mastitis: a case report. The Permanente Journal 15: 62-64.
• [46] Javadi E.H.S., Taghizadeh S., Haghdoost M., Oweysee H. 2014. Effect of probiotic in treatment of recurrent vulvovaginal candidiasis. International Journal of Current Research and Academic Review 2: 258-265.
• [47] Havlickova B., Czaika V.A., Friedrich M. 2008. Epidemiological trends in skin mycoses worldwide. Mycoses 51 (suppl. 4): 2-15.
• [48] Bhatia V.K., Sharma P.C. 2014. Epidemiological studies on dermatophytosis in human patients in Himachal Pradesh, India. SpringerPlus 3: 134. doi: 10.1186/2193-1801-3-134
• [49] Pires C.A.A., de Cruz N.F.S., Lobato A.M., de Sousa P.O., Carneiro R.O., Mendes A.M.D. 2014. Clinical, epidemiological and therapeutic profile of dermatomycosis. Anais Brasileiros de Dermatologia 89: 259-264. doi:10.1590/abd1806-4841.20142569
• [50] Oke O.O., Onayemi O., Olasode O.A., Omisore A.G., Oninla O.A. 2014. The prevalence and pattern of superficial fungal infections among school children in Ile-Ife, South-Western Nigeria. Dermatology Research and Practice: 1-7. doi:10.1155/2014/842917
• [51] Ismail N., Bloch K.C., McBride J.W. 2010. Human ehrlichiosis and anaplasmosis. Clinics of Laboratory Medicine 30 261-292. doi:10.1016/j.cli.2009.10.004
• [52] Weil A.A., Baron E.L., Brown C.M., Drapkin M.S. 2012. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clinic Proceedings 87: 233-239. doi:10.1016/j.mayocp.2011.09.008
• [53] Parkins M.D., Church D.L., Jiang X.Y., Gregson D.B. 2009. Human granulocytic anaplasmosis: first reported case in Canada. Canadian Journal of Infectious Diseases and Medical Microbiology 20: e100-e102.
• [54] Adeolu M., Gupta R.S. 2014. A phylogenomic and molecular marker based propos al for the division of the genus Borrelia into two genera: the emended genus Borrelia containing only the members of the relapsing fever Borrelia, and the genus Borreliella gen. nov. containing the members of the Lyme disease Borrelia (Borrelia burgdorferi sensu lato complex). Antonie van Leeuwenhoek 105: 1049-1072. doi: 10.1007/s10482-014-0164-x
• [55] Flisiak R., Pancewicz S. 2008. Diagnostyka i leczenie boreliozy z Lyme. Zalecenia Polskiego Towarzystwa Epidemiologów i Lekarzy Chorób Zakaźnych. Przegląd Epidemiologiczny 62: 193-199.
• [56] Palmieri J.R., King S., Case M., Santo A. 2013. Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia. International Medical Case Reports Journal 6: 99-105.
• [57] Dworkin M.S., Schwan T.G., Anderson Jr. D.E., Borchardt S.M. 2008. Tick-borne relapsing fever. Infectious Disease Clinics of North America 22: 449-468. doi:10.1016/j.idc.2008.03.006
• [58] Krause P.J., Narasimhan S., Wormser G.P., Rollend L., Fikrig E. 2016. Human Borrelia miyamotoi infection in the United States. The New England Journal of Medicine 368: 291-293. doi:10.1056/NEJMc1215469

Identyfikatory

DOI

10.17420/ap6204.61